Sue Anne Chew
- Cancer Research top 10%
- MicroRNA in disease regulation 3
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 8
-
- RNA Interference and Gene Delivery 6
-
- Prostate Cancer Treatment and Research 3
-
- 3D Printing in Biomedical Research 4
- Nanoplatforms for cancer theranostics 4
- Graphene and Nanomaterials Applications 3
-
- Ocular Oncology and Treatments 3
- Co-authors
- Serena DantiNicholas MitsiadesVijay Kumar EedunuriCristian CoarfaAntonios G. MikosF. Kurtis KasperJohn ShouChuandong Geng
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Cancer Research (4 papers)Oncogene (1 paper)
- Partner nations
- United StatesItalyGreece
In The Last Decade
Sue Anne Chew
29 papers receiving 883 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 206
- Biomaterials 136
- Molecular Biology 494
- Pulmonary and Respiratory Medicine 225
- Molecular Medicine 24
Countries citing papers authored by Sue Anne Chew
This map shows the geographic impact of Sue Anne Chew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Anne Chew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Anne Chew more than expected).
Fields of papers citing papers by Sue Anne Chew
This network shows the impact of papers produced by Sue Anne Chew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Anne Chew. The network helps show where Sue Anne Chew may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sue Anne Chew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 27 | |
| 9 | 2020 | 4 | |
| 10 | 2016 | 47 | |
| 11 | 2016 | 87 | |
| 12 | 2015 | 68 | |
| 13 | 2015 | 30 | |
| 14 | 2014 | 132 | |
| 15 | 2013 | 181 | |
| 16 | The Protein Kinase C (PKC)/Protein Kinase D (PKD)/Steroid Receptor Coactivator (SRC)-3 pathway is an important therapeutic target in Gα-mutant Uveal Melanomas | 2012 | 1 |
| 17 | 2011 | 38 | |
| 18 | 2010 | 37 | |
| 19 | 2010 | 27 | |
| 20 | 2010 | 19 |
About Sue Anne Chew
Sue Anne Chew is a scholar working on Biomaterials, Pharmaceutical Science and Complementary and Manual Therapy, having authored 31 papers that have together received 889 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (6 papers), 3D Printing in Biomedical Research (4 papers), Nanoplatforms for cancer theranostics (4 papers), MicroRNA in disease regulation (3 papers), Graphene and Nanomaterials Applications (3 papers), Prostate Cancer Treatment and Research (3 papers) and Ocular Oncology and Treatments (3 papers). The work is most often cited by research in Cancer Research (206 citations), Biomaterials (136 citations) and Molecular Biology (494 citations). Sue Anne Chew has collaborated with scholars based in United States, Italy and Greece. Frequent co-authors include Serena Danti, Nicholas Mitsiades, Vijay Kumar Eedunuri, Cristian Coarfa, Antonios G. Mikos, F. Kurtis Kasper, John Shou, Chuandong Geng, Richard A. Bond and Martin Zimmermann. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.